KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Teladoc Health (TDOC) EBIT Margin (2016 - 2026)

Teladoc Health's EBIT Margin history spans 13 years, with the latest figure at 10.06% for Q1 2026.

  • On a quarterly basis, EBIT Margin rose 910.0% to 10.06% in Q1 2026 year-over-year; TTM through Mar 2026 was 8.12%, a 3318.0% increase, with the full-year FY2025 number at 10.39%, up 2934.0% from a year prior.
  • EBIT Margin hit 10.06% in Q1 2026 for Teladoc Health, down from 5.6% in the prior quarter.
  • Over the last five years, EBIT Margin for TDOC hit a ceiling of 5.31% in Q4 2023 and a floor of 1179.69% in Q1 2022.
  • Historically, EBIT Margin has averaged 150.67% across 5 years, with a median of 10.98% in 2023.
  • Biggest five-year swings in EBIT Margin: crashed -116103bps in 2022 and later skyrocketed 116744bps in 2023.
  • Tracing TDOC's EBIT Margin over 5 years: stood at 598.32% in 2022, then skyrocketed by 99bps to 5.31% in 2023, then plummeted by -42bps to 7.53% in 2024, then increased by 26bps to 5.6% in 2025, then crashed by -80bps to 10.06% in 2026.
  • Business Quant data shows EBIT Margin for TDOC at 10.06% in Q1 2026, 5.6% in Q4 2025, and 8.29% in Q3 2025.